Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Verigen licenses Italian rights to anti-TNF-alpha product

Oct. 14, 1997

Eltenac efficacy demonstrated in osteoarthritis

Oct. 13, 1997

FDA grant awarded for research on Dupuytren's disease therapy

Oct. 8, 1997

Clinical pharmacokinetic profile of rhIL-10

Oct. 8, 1997

Celgene initiates clinical trials for novel TNF-alpha inhibitors

Oct. 6, 1997

BB-2983 development discontinued

Oct. 6, 1997

Wyeth-Ayerst to promote Immunex's ENBREL in U.S.

Oct. 3, 1997

Genelabs Technologies reports phase III results from SLE trial

Oct. 3, 1997

Boston Life Sciences reports phase III results for Therafectin

Oct. 2, 1997

New bradykinin antagonists from Sanofi

Oct. 1, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...